Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]

383 reported adverse events

Drugs of this class: BEMPEDOIC ACID BEMPEDOIC ACID AND EZETIMIBE

These side effects are most commonly reported by patients taking drugs of the Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] class:

# Side effect Count
0 MYALGIA 42
1 MUSCLE SPASMS 32
2 ARTHRALGIA 31
3 PAIN IN EXTREMITY 27
4 FATIGUE 19
5 DRUG INEFFECTIVE 18
6 HEADACHE 17
7 DIZZINESS 16
8 NAUSEA 16
9 RASH 16
See all common reactions for Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]

Drugs of the Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MEDICAL DEVICE SITE BRUISE 1 0.0200
1 LOW DENSITY LIPOPROTEIN ABNORMAL 4 0.0117
2 LIPIDS ABNORMAL 3 0.0064
3 INFESTATION 1 0.0060
4 HIGH DENSITY LIPOPROTEIN ABNORMAL 1 0.0060
5 ANION GAP ABNORMAL 1 0.0056
6 BLOOD TRIGLYCERIDES DECREASED 1 0.0039
7 MUSCLE DISCOMFORT 1 0.0037
8 BILIARY OBSTRUCTION 1 0.0036
9 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0033
See all enriched reactions for Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]